About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Neuropharma FDA Approvals Down in 2009 | Main | McGovern Institue for Brain Research at MIT Goes Web 2.0 »

February 9, 2010

The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics

Email This Entry

Posted by Zack Lynch

120_Neurodiagnostics_Report_Cover_200.jpgWe've recently published "The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics," a report published by NeuroInsights. It is a fully updated second annual industry insider report detailing markets and emerging diagnostics in neurology and psychiatry. In addition to the massive unmet markets, long-term growth in neurodiagnostics is being driven by technology advances and equipment upgrades in neuroimaging; new biomarkers and imaging protocols for early diagnosis and disease monitoring; and increased use of imaging and informatics in drug and device development.

NeuroInsights has identified three primary markets in neurodiagnostics which are discussed in detail in this report: Neuroimaging: Medical equipment and reagents for research, diagnostics and patient monitoring, including MRI, CT, PET, SPECT, EEG and MEG. In vitro diagnostics: Genetic testing, biomarker assays and chemical profiling of human samples, including urine, blood, cerebral spinal fluid and tissue. Neuroinformatics: Multidimensional databases and software systems that store and analyze data from the genetic to the behavioral level.

Partial list of companies discussed in the report include: Abbot Diagnostics, Adlyfe, Advanced Brain Monitoring, Applied NeuroSolutions, Aspect Medical (Covidien), Astro-Med, Athena Diagnostics, Avacta, Avid Radiopharmaceuticals, Bayer, BioBehavioral Diagnostics, Brain Resource, BrainScope, Cambridge Cognition, CNS Response, CNS Vital, CogState, Compumedics, Cytox, Electrical Geodesics, Elminda, ExonHit, GE, GeneNews, g-Nostics, Hitachi, Johnson & Johnson, Kappametrics, Knopp Neurosciences, Michael J. Fox Foundation, Natus Medical, NeuroMetrix, Neuronetrix, Neuroptix, NeuroTrax, NeuroVigil, NeuroVista, Nymox, Odin, Optima Neuroscience, Optimal Medicine, Orasi Medical, Ortho-Clinical Diagnostics, Pfizer, Philips, PhysioSonics, Pritzker Neuropsychiatric Consortium, Psynova, Quest Diagnostics, Roche, Rules-Based, Medicine, Satoris, Siemens, SleepMed, The Genetics Company, TheraGenetics, Toshiba,Transcription Diagnostics, Vanda, Wyeth and more. To view the full list of 150 companies included in this extensive report, click here.

Comments (0) + TrackBacks (0) | Category: Neurodiagnostics


Email this entry to:

Your email address:

Message (optional):

Chinese Cover of The Neuro Revolution
The Neuro Revolution Lands In China
How Neuroscience Will Change the World - My Interview on
Neuroscience Hearing on Capitol Hill Wednesday Sept 29, 2pm
The Neuro Revolution Published in Japan as "Neuro Wars"
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20